158 related articles for article (PubMed ID: 16628264)
21. Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor RORalpha.
Genoux A; Dehondt H; Helleboid-Chapman A; Duhem C; Hum DW; Martin G; Pennacchio LA; Staels B; Fruchart-Najib J; Fruchart JC
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1186-92. PubMed ID: 15790933
[TBL] [Abstract][Full Text] [Related]
22. The orphan nuclear receptor, RORalpha, regulates gene expression that controls lipid metabolism: staggerer (SG/SG) mice are resistant to diet-induced obesity.
Lau P; Fitzsimmons RL; Raichur S; Wang SC; Lechtken A; Muscat GE
J Biol Chem; 2008 Jun; 283(26):18411-21. PubMed ID: 18441015
[TBL] [Abstract][Full Text] [Related]
23. Extracellular signal-regulated kinase-2 phosphorylates RORalpha4 in vitro.
Lechtken A; Hörnig M; Werz O; Corvey N; Zündorf I; Dingermann T; Brandes R; Steinhilber D
Biochem Biophys Res Commun; 2007 Jul; 358(3):890-6. PubMed ID: 17512500
[TBL] [Abstract][Full Text] [Related]
24. RORalpha: an orphan nuclear receptor on a high-cholesterol diet.
Willson TM
Structure; 2002 Dec; 10(12):1605-6. PubMed ID: 12467566
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism.
Meyer T; Kneissel M; Mariani J; Fournier B
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9197-202. PubMed ID: 10900268
[TBL] [Abstract][Full Text] [Related]
26. NR4A nuclear orphan receptors: protective in vascular disease?
Pols TW; Bonta PI; de Vries CJ
Curr Opin Lipidol; 2007 Oct; 18(5):515-20. PubMed ID: 17885421
[TBL] [Abstract][Full Text] [Related]
27. RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.
Serra HG; Duvick L; Zu T; Carlson K; Stevens S; Jorgensen N; Lysholm A; Burright E; Zoghbi HY; Clark HB; Andresen JM; Orr HT
Cell; 2006 Nov; 127(4):697-708. PubMed ID: 17110330
[TBL] [Abstract][Full Text] [Related]
28. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
Evans MJ; Mahaney PE; Borges-Marcucci L; Lai K; Wang S; Krueger JA; Gardell SJ; Huard C; Martinez R; Vlasuk GP; Harnish DC
Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G543-52. PubMed ID: 19136377
[TBL] [Abstract][Full Text] [Related]
29. Age-related phenotypes in the staggerer mouse expand the RORalpha nuclear receptor's role beyond the cerebellum.
Jarvis CI; Staels B; Brugg B; Lemaigre-Dubreuil Y; Tedgui A; Mariani J
Mol Cell Endocrinol; 2002 Jan; 186(1):1-5. PubMed ID: 11850116
[TBL] [Abstract][Full Text] [Related]
30. Novel peroxisome proliferator activated receptor-alpha agonists.
Fruchart JC
Am J Cardiol; 2007 Dec; 100(11 A):n41-6. PubMed ID: 18047852
[TBL] [Abstract][Full Text] [Related]
31. Neurodegeneration: a case of arrested development?
La Spada AR
Cell; 2006 Nov; 127(4):669-71. PubMed ID: 17110325
[TBL] [Abstract][Full Text] [Related]
32. The orphan nuclear receptor Rev-erbalpha: a transcriptional link between circadian rhythmicity and cardiometabolic disease.
Fontaine C; Staels B
Curr Opin Lipidol; 2007 Apr; 18(2):141-6. PubMed ID: 17353661
[TBL] [Abstract][Full Text] [Related]
33. Retinoic acid receptor-related orphan receptor α reduces lipid droplets by upregulating neutral cholesterol ester hydrolase 1 in macrophages.
Matsuoka H; Tokunaga R; Katayama M; Hosoda Y; Miya K; Sumi K; Ohishi A; Kamishikiryo J; Shima A; Michihara A
BMC Mol Cell Biol; 2020 Apr; 21(1):32. PubMed ID: 32321446
[TBL] [Abstract][Full Text] [Related]
34. X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha.
Kallen JA; Schlaeppi JM; Bitsch F; Geisse S; Geiser M; Delhon I; Fournier B
Structure; 2002 Dec; 10(12):1697-707. PubMed ID: 12467577
[TBL] [Abstract][Full Text] [Related]
35. Thiazolidine diones, specific ligands of the nuclear receptor retinoid Z receptor/retinoid acid receptor-related orphan receptor alpha with potent antiarthritic activity.
Missbach M; Jagher B; Sigg I; Nayeri S; Carlberg C; Wiesenberg I
J Biol Chem; 1996 Jun; 271(23):13515-22. PubMed ID: 8662835
[TBL] [Abstract][Full Text] [Related]
36. Death receptors and their ligands in atherosclerosis.
Kavurma MM; Tan NY; Bennett MR
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1694-702. PubMed ID: 18669890
[TBL] [Abstract][Full Text] [Related]
37. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
38. Cerebellar purkinje cell loss in heterozygous rora+/- mice: a longitudinal study.
Doulazmi M; Capone F; Frederic F; Bakouche J; Lemaigre-Dubreuil Y; Mariani J
J Neurogenet; 2006; 20(1-2):1-17. PubMed ID: 16807193
[TBL] [Abstract][Full Text] [Related]
39. Enhanced susceptibility of staggerer (RORalphasg/sg) mice to lipopolysaccharide-induced lung inflammation.
Stapleton CM; Jaradat M; Dixon D; Kang HS; Kim SC; Liao G; Carey MA; Cristiano J; Moorman MP; Jetten AM
Am J Physiol Lung Cell Mol Physiol; 2005 Jul; 289(1):L144-52. PubMed ID: 15778248
[TBL] [Abstract][Full Text] [Related]
40. Identification of insulin as a novel retinoic acid receptor-related orphan receptor α target gene.
Kuang J; Hou X; Zhang J; Chen Y; Su Z
FEBS Lett; 2014 Mar; 588(6):1071-9. PubMed ID: 24583012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
